期刊文献+

抗Sm抗体阳性系统性红斑狼疮临床特征学研究 被引量:4

STUDY ON THE CLINICAL FEATURES OF SYSTEMIC LUPUS ERYTHEMATOSUS WITH POSITIVE ANTI-Sm ANTIBODY
在线阅读 下载PDF
导出
摘要 目的了解抗Sm抗体阳性系统性红斑狼疮(SLE)病人的临床特征。方法对42例抗Sm抗体阳性的SLE门诊病人临床资料进行分析,并与40例抗Sm抗体阴性SLE病人的临床资料进行比较。结果抗Sm抗体阳性的SLE病人病程较短,光敏感、关节痛、白细胞减少、蛋白尿下降、补体C3下降的发生率均高于对照组(t=7.38,Х^2=3.60~10.98,P〈0.05、0.01)。结论抗Sm抗体阳性SLE病人的临床表现明显,更易于做出早期诊断。抗Sm抗体阳性病人更易早期出现肾脏损害,提示预后不良。 Objective To comprehend the clinical features of positive anti-Sin antibody (ASA) patients with systemic lupus erythematosus (SLE). Methods Clinical data of 42 SLE patients with positive ASA were analyzed and compared with 42 SLE ones with negative ASA. Results The course of SLE patients with positive antibody was shorter than that of those with negative antibody, and more photaesthesia, arthralgia, leucopenia, decrease of proteinuria and complement C3 (t =7. 38;Х^2= 3.60-10.98;P〈0.05,0.01). Conclusion The clinical manifestations of anti-Sin positive SLE patients are more obvious and early diagnosis is easier to be made, the prognosis is poor because of early damage of the kidney.
出处 《青岛大学医学院学报》 CAS 2009年第6期567-568,共2页 Acta Academiae Medicinae Qingdao Universitatis
关键词 红斑狼疮 系统性 抗SM抗体 疾病特征 Lupus erythematosus, systemic Anti-Sin antibody Genius morbi
  • 相关文献

参考文献5

  • 1刘丰海,原江水,宋卫青.系统性红斑狼疮病人自身抗体的变化及意义[J].青岛大学医学院学报,2009,45(2):173-173. 被引量:4
  • 2潘琳,王吉波,谢荣爱.系统性红斑狼疮的辅助检查[J].青岛大学医学院学报,2007,43(2):187-188. 被引量:7
  • 3BEAUFILS M, KOUKO F, MINGNON F, et al. Clinical singificance of anti-Sm antibodies in systemic lupus erythematosus [J]. AmJ Med, 1983,74:201.
  • 4JANWITYANUCHIT S, VERASERTNIYON O, VANICHAPUMTU M, et al. Anti-Sm: its predietive value in systemic lupus erythematosus [J]. Clin Rheumaiol, 1993, 12 :350.
  • 5SINGH R R, MALAVIYA A N, KAILASH S, et al. Clinical significance of anti-Sin antibody in systemic lupus erythematosus & related disorders[J]. Indian J Med Res, 1991,94:206.

二级参考文献2

共引文献9

同被引文献39

  • 1王丽峰,封其华,李晓忠.儿童系统性红斑狼疮30例临床及肾脏病理分析[J].中国血液流变学杂志,2006,16(4):632-633. 被引量:3
  • 2吴东海,祖宁,张荣富.AnuA﹑抗dsDNA及抗C1q抗体在系统性红斑狼疮及狼疮肾炎诊断中的作用[J].中日友好医院学报,2007,21(1):5-8. 被引量:11
  • 3HOCHBERG M C.Updating the American college of rheuma-tology revised criteria for the classification of systemic lupuserythematosus[J].Arthritis Rheum,1997,40:1725.
  • 4HOFFMAN I E A,LAUWERYS B R,DEKEYSER F,et al.Juvenile-onset systemic lupus erythemotosis:different clinicaland serological pattern than adult-onset systemic lupus erythe-matosus[J].Ann Rheum Dis,2009,68:412-415.
  • 5HAREL L,SANDBORG C,LEE T,et al.Neuropsychiatricmanifestations in pediatric systemic lupus erythematosus andassociation with antiphospholipid antibodies[J].J Rheumatol,2006,33:1873-1877.
  • 6YU H H,WANG L C,LEE J H,et al.Lymphopenia is asso-ciated with neuropsychiatric manifestations and disease activityin paediatric systemic lupus erythematosus patients[J].Rheu-matology,2007,46:1492-1494.
  • 7MORADINEJAD M H,ZAMANI G R,KIANI A R,et al.Clinical features of juvenile systemic lupus erythematosusinIranian children[J].Acta Reumatol Port,2008,33:63-67.
  • 8Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. TheCommittee on Prognosis Studies in SLE. Arthritis Rheum, 1992, 35(6): 630-640.
  • 9Barada FA Jr, Andrews BS, Davis JS 4th, et al. Antibodies to Sm in patients with systemic lupus erythematosus. Correlation of Sm antibody titers with disease activity and other laboratory parameters. Arthritis Rheum, 1981, 24( 10): 1236-1244.
  • 10Mahler M. Sm peptides in differentiation of autoimmune diseases. Adv Clin Chem, 2011, 54: 109-128.

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部